X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (86012) 86012
Publication (4719) 4719
Book Chapter (868) 868
Book Review (613) 613
Conference Proceeding (167) 167
Dissertation (145) 145
Book / eBook (123) 123
Magazine Article (65) 65
Web Resource (33) 33
Newsletter (23) 23
Journal / eJournal (16) 16
Data Set (13) 13
Government Document (8) 8
Reference (8) 8
Newspaper Article (6) 6
Paper (5) 5
Trade Publication Article (5) 5
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54590) 54590
index medicus (37469) 37469
male (34826) 34826
female (33122) 33122
middle aged (26265) 26265
percutaneous coronary intervention (25902) 25902
aged (23789) 23789
cardiac & cardiovascular systems (22700) 22700
treatment outcome (19321) 19321
adult (12913) 12913
surgery (11855) 11855
retrospective studies (9490) 9490
risk factors (9356) 9356
aged, 80 and over (8181) 8181
time factors (8160) 8160
stents (7982) 7982
follow-up studies (6952) 6952
mortality (6897) 6897
care and treatment (6347) 6347
management (6304) 6304
angioplasty (6292) 6292
prospective studies (5714) 5714
radiology, nuclear medicine & medical imaging (5592) 5592
coronary angiography (5549) 5549
medicine & public health (5346) 5346
cardiovascular (5328) 5328
cardiology (5305) 5305
abridged index medicus (5232) 5232
outcomes (5183) 5183
complications (4865) 4865
urology & nephrology (4735) 4735
peripheral vascular disease (4718) 4718
analysis (4671) 4671
myocardial infarction (4660) 4660
drug-eluting stents (4630) 4630
transluminal angioplasty (4594) 4594
animals (4429) 4429
percutaneous coronary intervention - adverse effects (4356) 4356
medicine, general & internal (4185) 4185
prognosis (4055) 4055
pharmacology & pharmacy (4050) 4050
myocardial infarction - therapy (4027) 4027
percutaneous coronary intervention - methods (3902) 3902
adolescent (3651) 3651
stent (3609) 3609
risk assessment (3590) 3590
patients (3505) 3505
cardiac patients (3504) 3504
coronary artery disease (3496) 3496
disease (3454) 3454
heart attacks (3433) 3433
health aspects (3331) 3331
therapy (3305) 3305
follow-up (3230) 3230
intervention (3222) 3222
acute myocardial-infarction (3205) 3205
risk (3184) 3184
percutaneous transluminal angioplasty (3161) 3161
angiography (3117) 3117
coronary artery disease - therapy (3099) 3099
thrombosis (3039) 3039
clinical neurology (2998) 2998
percutaneous (2989) 2989
usage (2944) 2944
diagnosis (2890) 2890
trial (2877) 2877
experience (2865) 2865
electrocardiography (2838) 2838
coronary heart disease (2827) 2827
tomography, x-ray computed (2813) 2813
clopidogrel (2737) 2737
orthopedics (2705) 2705
research (2682) 2682
percutaneous endoscopic gastrostomy (2657) 2657
heart attack (2652) 2652
revascularization (2629) 2629
child (2624) 2624
predictive value of tests (2558) 2558
impact (2551) 2551
angioplasty, balloon, coronary (2539) 2539
registries (2533) 2533
percutaneous-absorption (2508) 2508
implantation (2500) 2500
recurrence (2470) 2470
platelet aggregation inhibitors - therapeutic use (2468) 2468
cardiovascular diseases (2437) 2437
myocardial-infarction (2423) 2423
cardiovascular disease (2351) 2351
incidence (2305) 2305
percutaneous coronary intervention - instrumentation (2302) 2302
metaanalysis (2296) 2296
young adult (2294) 2294
patient outcomes (2280) 2280
myocardial infarction - mortality (2263) 2263
prosthesis design (2248) 2248
gastroenterology & hepatology (2229) 2229
artery-disease (2224) 2224
percutaneous nephrolithotomy (2221) 2221
coronary artery bypass (2192) 2192
cardiology and cardiovascular medicine (2109) 2109
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (56) 56
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (78736) 78736
German (2331) 2331
French (1518) 1518
Japanese (1514) 1514
Spanish (1258) 1258
Chinese (605) 605
Korean (538) 538
Portuguese (511) 511
Russian (442) 442
Italian (356) 356
Polish (345) 345
Turkish (248) 248
Czech (140) 140
Hungarian (65) 65
Dutch (39) 39
Slovak (24) 24
Bulgarian (18) 18
Danish (18) 18
Serbian (14) 14
Persian (13) 13
Swedish (13) 13
Croatian (11) 11
Norwegian (11) 11
Slovenian (11) 11
Icelandic (9) 9
Hebrew (7) 7
Lithuanian (6) 6
Ukrainian (6) 6
Bosnian (5) 5
Romanian (5) 5
Arabic (3) 3
Finnish (3) 3
Indonesian (3) 3
Belarusian (1) 1
Estonian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 10, pp. 963 - 972
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2016, Volume 9, Issue 4, pp. 341 - 351
Journal Article
European Heart Journal, ISSN 0195-668X, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin
Journal Article